Serum fetuin-B has been shown in clinical investigations to be favorably correlated with indicators of adipose tissue inflammation [82,83], including IL-6 and TNF-α, as well as the degree of hepatic steatosis [84]. Here, FETUB is linked to fatty liver disease.